Evaluation of Potentially Prolactin-Related Adverse Events and Sexual Maturation in Adolescents with Schizophrenia Treated with Paliperidone Extended-Release (ER) for 2 Years: A Post Hoc Analysis of an Open-Label Multicenter Study. [electronic resource]
- CNS drugs Sep 2017
- 797-808 p. digital
Publication Type: Journal Article; Multicenter Study
1179-1934
10.1007/s40263-017-0437-9 doi
Adolescent Age Factors Antipsychotic Agents--administration & dosage Child Delayed-Action Preparations Female Humans Hyperprolactinemia--chemically induced Male Paliperidone Palmitate--administration & dosage Prolactin--blood Risk Factors Schizophrenia--drug therapy Sex Factors Sexual Maturation--drug effects Time Factors